A prospective clinical study of endoscopic surgery combined with chemotherapy for early nasopharyngeal carcinoma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800019206

Enrollment

Unknown

Registered

2018-10-31

Start date

2018-11-30

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

experimental group:operation

control group:Radiation therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in this clinical trial and sign a written informed consent; 2. KPS score greater than or equal to 70; 3. Pathological staging: non-keratogenic carcinoma was divided into differentiated and undifferentiated types, Keratinous squamous cell carcinoma, Basal squamous cell carcinoma; 4. The initial diagnosis was t1-2n0m0, and the surgical margin was negative; 5. Blood routine, electrolyte, coagulation function, etc. meet the standards of chemotherapy and surgery.

Exclusion criteria

Exclusion criteria: 1.ECT or PET suggest patients with distant metastasis; 2.MR and CT suggested limited to nasopharynx or only invaded the nasal cavity, oral cavity and parapharyngeal space, with unilateral or bilateral lymph node enlargement; 3. Patients who cannot tolerate surgery; 4. With history of severe basic diseases and surgery; 5. Accepted any anti-cancer treatment before; 6. contraindications for chemotherapy.

Design outcomes

Primary

Measure	Time frame
survival rate;	—

Countries

China

Contacts

Public ContactQiu Qianhui

Zhujiang Hospital of Southern Medical University

qiuqianhui@hotmail.com+86 13922186037

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026